Teva Pharmaceutical Industries Ltd (TEVA)

16.49
0.52 3.06
NYSE : Health Care
Prev Close 17.01
Open 17.01
Day Low/High 16.45 / 17.02
52 Wk Low/High 16.73 / 53.96
Volume 19.94M
Avg Volume 15.36M
Exchange NYSE
Shares Outstanding 1.02B
Market Cap 17.31B
EPS 0.10
P/E Ratio 3.32
Div & Yield 0.34 (2.00%)

Latest News

We're Buying More Allergan

Drugmaker has survived negative impact of Teva deal.

Teva Must Clear Three Big Hurdles to Reclaim Its Perch

Teva Must Clear Three Big Hurdles to Reclaim Its Perch

Analysts are most critical about Teva's plan to cut $5 billion in debt by the end of the year.

Teva Announces Exclusive Launch Of Generic Axiron® In The United States

Teva Announces Exclusive Launch Of Generic Axiron® In The United States

Teva Pharmaceutical Industries Ltd., (NYSE and TASE: TEVA) today announced the launch of generic Axiron ®1 (testosterone) topical solution CIII, 30 mg/1.

Oversold Small-Cap Biotech Names

Oversold Small-Cap Biotech Names

I am working incrementally into some small stocks with great long-term value.

Valeant CEO Confident Divestitures Can Successfully Pare Debt, Skeptics Remain

Valeant CEO Confident Divestitures Can Successfully Pare Debt, Skeptics Remain

For his 'Executive Decision' segment, Cramer again sat down with Joe Papa, chairman and CEO of Valeant

European Pharma Companies Slip on MS Pricing Probe

European Pharma Companies Slip on MS Pricing Probe

House Democrats start probe into MS drug prices

PayPal, Marriott International, Randgold Resources: 'Mad Money' Lightning Round

PayPal, Marriott International, Randgold Resources: 'Mad Money' Lightning Round

Jim Cramer is bullish on PayPal, Marriott International, Randgold Resources, and Kirkland Lake.

The Market Is Not About Washington: Cramer's 'Mad Money' Recap (Wed 8/16/17)

The Market Is Not About Washington: Cramer's 'Mad Money' Recap (Wed 8/16/17)

Jim Cramer says despite chaos in Washington, the market's not falling. Why? Because stocks aren't a referendum on the presidency.

Valeant Pharmaceuticals: Cramer's Top Takeaways

Valeant Pharmaceuticals: Cramer's Top Takeaways

Joe Papa, chairman and CEO of Valeant Pharmaceuticals International, talks to Jim Cramer about his company's turnaround.

Closing Bell: Teva Tumbles and Trump Disbands CEO Councils

Closing Bell: Teva Tumbles and Trump Disbands CEO Councils

Domestic politics take the spotlight yet again

Teva Stock Tumbles Again, Citi Downgrades, Says 'We Have Been Wrong'

Teva Stock Tumbles Again, Citi Downgrades, Says 'We Have Been Wrong'

Citigroup cut its rating for the struggling generic drug maker to 'neutral'.

News Doesn't Alter Our Positions

Trump deflates rally a bit, but we'd buy if we could.

Teva Is Cheap, Not Dead

Teva Is Cheap, Not Dead

The drug stock deserved to go down, but the resulting selloff is an overreaction.

International Paper, Inogen, Teva Pharmaceuticals: 'Mad Money' Lightning Round

International Paper, Inogen, Teva Pharmaceuticals: 'Mad Money' Lightning Round

Jim Cramer likes International Paper and Inogen, but he's bearish on Teva Pharmaceuticals.

Fantasy Football and Picking Stocks: Cramer's 'Mad Money' Recap (Tues 8/15/17)

Fantasy Football and Picking Stocks: Cramer's 'Mad Money' Recap (Tues 8/15/17)

Jim Cramer says a well-diversified portfolio is a lot like a well-balanced and winning football team.

Indexes Don't Mind Poor Stock Action

This isn't normally what you see in good markets.

Teva Falls Hard, Loses Title as Israel's Biggest Firm

Teva Falls Hard, Loses Title as Israel's Biggest Firm

Teva just isn't 'the people's stock' it used to be.

Mylan Badly Needs Help from FDA to Escape its Woes and Deliver These Key Drugs

Mylan Badly Needs Help from FDA to Escape its Woes and Deliver These Key Drugs

Mylan execs have criticized the FDA, which they say has been too slow to approve competitors to complex drugs.

Israel's Stock Market Is Having a Disastrous Week

Israel's Stock Market Is Having a Disastrous Week

Teva's not the only one struggling to stay afloat in Israel.

Valeant and Teva Share Similar Ambitions With Similar Pitfalls

Valeant and Teva Share Similar Ambitions With Similar Pitfalls

Here's what you need to know now for Wed., Aug. 9.

Teva Ramping Up Asset Sales to Preserve Credit Rating

Teva Ramping Up Asset Sales to Preserve Credit Rating

Moody's kept Teva as investment grade because it remains the largest generic drug company in the world and still has strong cash flow.

Think for Yourself

Think for Yourself

If you want to reap big gains, read, understand and buy when the numbers make sense.

Israeli Officials Ask Teva to Delay Planned Job Cuts

Israeli Officials Ask Teva to Delay Planned Job Cuts

Teva receives special tax benefits from Israel.

New Trades: Pitney Bowes, Diageo

New Trades: Pitney Bowes, Diageo

A couple of new prospects emerge.

FedEx to Deliver More Value; Apple Watch Upgrades to Benefit Intel -ICYMI

FedEx to Deliver More Value; Apple Watch Upgrades to Benefit Intel -ICYMI

Here's what you need to know now for Monday, Aug. 7.

Allergan: Cramer's Top Takeaways

Allergan: Cramer's Top Takeaways

Brent Saunders, chairman and CEO of Allergan, tells Jim Cramer he's bullish on new treatments for depression.

Buy These High-Octane Stocks on a Dip: Cramer's 'Mad Money' Recap (Monday 8/7/17)

Buy These High-Octane Stocks on a Dip: Cramer's 'Mad Money' Recap (Monday 8/7/17)

Jim Cramer says history doesn't have to repeat itself. You don't want to miss another opportunity in the highly visible FANG-style stocks.